Migraine treated with an antihistamine-analgesic combination.
D000082:Acetaminophen / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D003061:Codeine / Q000627:therapeutic use*; D003501:Cyclizine / Q000627:therapeutic use; D004878:Ergotamine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D009325:Nausea / Q000139:chemically induced; D010879:Piperazines / Q000627:therapeutic use; D013386:Succinates / Q000627:therapeutic use; D013997:Time Factors; D014839:Vomiting / Q000188:drug therapy
D006634:Histamine H1 Antagonists; D010879:Piperazines; D013386:Succinates; D000082:Acetaminophen; D004878:Ergotamine; D003501:Cyclizine; D003061:Codeine